may delivered a positive earnings surprise Avid Bioservices Inc (NASDAQ:CDMO)

0
17

Earnings results for Avid Bioservices Inc (NASDAQ:CDMO)

Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingApr 2020 , the consensus EPS* forecast has remained the same over the past week at -0.1 and decreased over the past month from -0.09 to -0.1(11.11%). none raised and none lowered their forecast. For the fiscal year ending Apr 2020 , the consensus EPS* forecast has remained the same over the past week at -0.29 and decreased over the past month from -0.28 to -0.29(3.57%). none raised and none lowered their forecast.

Analyst Opinion on Avid Bioservices Inc (NASDAQ:CDMO)

4 Wall Street analysts have issued ratings and price targets for Avid Bioservices in the last 12 months. Their average twelve-month price target is $9.38, suggesting that the stock has a possible upside of 50.48%. The high price target for CDMO is $11.00 and the low price target for CDMO is $7.50. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of “Buy.”

Avid Bioservices has received a consensus rating of Buy. The company’s average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $9.38, Avid Bioservices has a potential upside of 50.5% from its current price of $6.23. Avid Bioservices has received no research coverage in the past 90 days.

Dividend Strength: Avid Bioservices Inc (NASDAQ:CDMO)

Avid Bioservices does not currently pay a dividend. Avid Bioservices does not have a long track record of dividend growth.

Insiders buying/selling: Avid Bioservices Inc (NASDAQ:CDMO)

In the past three months, Avid Bioservices insiders have not sold or bought any company stock. Only 1.20% of the stock of Avid Bioservices is held by insiders. 50.13% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Avid Bioservices Inc (NASDAQ:CDMO

Earnings for Avid Bioservices are expected to grow in the coming year, from ($0.29) to ($0.04) per share. The P/E ratio of Avid Bioservices is -32.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Avid Bioservices is -32.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Avid Bioservices has a P/B Ratio of 6.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here